Current issues related to import substitution were discussed at the meeting of the Expert Council
The meeting of the Expert Council on Development of Biotechnologies of Pharmaceutical and Medical Industry of the State Duma Committee on Industry was held on July 14. The main topic for discussion was "Current issues related to import substitution: balance between protection measures and the interests of patients".
The event gathered the representatives of federal executive authorities, educational institutions, nonprofit organizations, representatives of the patient community, as well as the Russian pharmaceutical and medical industry.
The speakers noted in their reports that every year the pace of the Russian pharmaceutical industry development grows substantially, and despite crisis phenomena in the economy, the industry is still stable and attractive for all, including foreign investors, thanks to the government policy that supports the pharmaceutical industry.
Olga Kolotilova, the Director of the Department of Pharmaceutical and Medical Industry of the Ministry of Industry and Trade of the Russian Federation, noted that the market share of the drugs of local production has increased by 24-28.5% within a year and a half. Over the last five years, 22 new manufacturing sites, related to the most socially significant areas, were launched. At the same time the Russian companies have a cost-effective approach, especially, in the aspect of public costs.
Dmitry Chagin, the Chairman of the Board of the Association of the Eurasian Pharmaceutical Manufacturers, noted that a wide range of measures to stimulate local manufacturers have been developed at the state level. He also expressed the hope that they would continue to expand and deepen in the coming years. One of the most important tasks, which today comes to the forefront, is connected with the overcoming of a stereotype that foreign products are better than local ones. Without the adoption of import substitution policy by all parties it is impossible to achieve significant results. He emphasized that it is extremely important to inform the public about the achievements of the local pharmaceutical industry and prevent the flow of distorted information, discrediting the policy of the state in this aspect. For this purpose it was proposed to include in the resolution of the Ministry of Justice a recommendation to verify the existence of non-profit organizations, representing the interests of foreign pharmaceutical manufacturers, in the state register of nonprofit organizations, acting as foreign agent, and recommend to the mass media to form their plans based on the need to inform the public about the achievements of the local pharmaceutical industry.